Donate to HSC
Donate to HSC
Facebook
Twitter
Instagram

FDA APPROVES GENENTECH’S HEMLIBRA

® (EMICIZUMAB-KXWH) FOR HEMOPHILIA A WITH INHIBITORS – First new medicine in nearly 20 years to treat people with hemophilia A with inhibitors – – HEMLIBRA substantially reduced bleeds in adults and children – – Only medicine that can be self-administered once weekly...

Updates on Insurance Assistance Programs

Updates on Insurance Assistance Programs Help with Covering Insurance Costs January 30, 2017 Affordability remains an issue for the bleeding disorders community.  There are some excellent resources available to assist our community, whether it is to help cover your...